Fingolimod (Gilenya▼): updated advice about the risks of serious liver injury and herpes meningoencephalitis

Liver monitoring requirements and discontinuation criteria for fingolimod have been updated following reports of serious liver injury.

Join OnMedica and benefit from:

  • Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
  • High-quality, evidence-based content developed by expert editors and clinicians
  • Articles, quizzes, videos, visual summaries and more
  • Regulatory alerts and round-up of medical journals
  • New content added daily, so you know you’re always up to date

Existing members Sign in